SUANNUTRA, under the umbrella of life science giant SUANFARMA, has announced the appointment of Anthony Weston as its new CEO. This move is strategically poised to catapult the company to the forefront of the nutraceutical market by intensifying its customer-centric approach.
SUANFARMA, since its inception in 1993, has grown into a dominant force in the development, production, and sale of ingredients for the pharmaceutical, veterinary, and nutraceutical markets. The appointment is aimed at harnessing Weston’s extensive background in global business management and leadership to bolster SUANNUTRA’s ambitions for global expansion.
Using its core brands – Gonmisol, Monteloeder, and Suanfarma USA – SUANNUTRA seeks to champion growth in branded and innovative ingredients while fortifying its market presence in functional and essential ingredients. This aligns with the company’s unwavering commitment to quality and innovation.
Francisco Fernández, who remains at the helm of SUANFARMA, emphasized the significance of Anthony’s appointment, stating, “Anthony’s inspiring leadership, strategic vision, and ability to face challenges head-on are assets that will take SUANNUTRA to new heights.”
With clients in 50 countries and a strong network in Europe, USA, and Asia, SUANNUTRA is poised as a global player. Under Weston’s leadership, the company is set to foster innovation and expand its science-backed product line.
